Megan Blewett joined Venrock in 2017 and focuses on biotech and pharmaceutical investments. Prior to Venrock, Megan was a Hertz Fellow and NSF Fellow with Ben Cravatt at The Scripps Research Institute, where she earned a PhD in chemistry. Her PhD work explored the mechanism of action of the multiple sclerosis therapeutic Tecfidera and helped form the foundation of the biotech company Vividion. Megan also has a longstanding interest in healthcare analytics and has consulted for Google’s medical condition search team.
Megan received an AB/AM in chemistry from Harvard University, where she spent nearly all four years working in the lab of chemistry Nobel Laureate EJ Corey and was awarded the Thomas T. Hoopes Prize for her senior thesis research.